Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1991-11-18
1993-04-20
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 9, 514492, 514836, A61K 4904, A61K 3128
Patent
active
052040852
ABSTRACT:
Paramagnetic chelates, as for example, Gadolinium diethylenetriaminepentaacetic acid (DTPA), manganese, ethylenediaminetetraacetic acid (EDTA), and others used as X-ray contrast agents are more toxic acutely when injected in high concentration or at rapid rates. The use of effective amounts of calcium in the form of, calcium chloride, calcium gluconate, or balanced salt solutions substantially reduces this toxicity without the need to add additional ligand.
REFERENCES:
patent: 4176173 (1979-11-01), Winchell et al.
patent: 4478816 (1984-10-01), Ledley et al.
patent: 4647447 (1987-03-01), Gries et al.
patent: 4810782 (1989-03-01), Theodoropulos
patent: 4822594 (1989-04-01), Gibby
patent: 5082649 (1992-01-01), VanDeripe
Hollinden Gary E.
Hollrah Glennon H.
Mallinckrodt Medical Inc.
LandOfFree
Method for enhancing the safety of metal-ligand chelates as X-ra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing the safety of metal-ligand chelates as X-ra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing the safety of metal-ligand chelates as X-ra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1524581